Red Hot Healthcare
  • About Steve
  • My Portfolio
  • Podcast
  • Interviews
  • Contact
  • TODAY’S NEWS
    • Hospitals/Systems
    • Digital Health & Tech
    • Payers
    • Biotech
    • Pharma
    • Covid
    • Blockchain and more
Select Page

FDA to convene advisers on review of RSV vaccines from GSK, Pfizer

by | | Biotech

The agency is currently assessing applications filed by the two companies for what they hope will become the first vaccines against the virus in older adults.

3 more biotechs announce layoffs as industry cost-cutting continues

by | | Biotech

Evelo Biosciences, Quince Therapeutics and Inovio are the latest to pare down workforces in the face of clinical setbacks and depressed stock prices.

Novartis confirms it has stopped development of experimental Huntington’s drug

by | | Biotech

Termination of the branaplam program, according to Novartis, was due to an “overall assessment of the risk-benefit profile” observed in a mid-stage clinical trial that raised safety concerns last year.

Head of FDA gene therapy office set to retire in March

by | | Biotech

Wilson Bryan, a key decision maker in the agency’s oversight of genetic medicines, will leave next month amid an organizational revamp of his office, the FDA confirmed.

Pfizer forecasts steep decline in COVID vaccine, drug sales

by | | Biotech

The company expects yearly revenue from Comirnaty and Paxlovid to fall by nearly two thirds in 2023 amid lower vaccination rates and a shift to private market sales.
« Older Entries

Recent Posts

  • Free Covid Care Will Be Gone Soon. Should You Worry? – Bloomberg
  • Cidara Therapeutics expands partnership with WuXi XDC
  • DeSantis’s record on COVID-19: Here’s what he said and did – The Hill
  • Endevica Bio and Orbit Discovery unite to boost cachexia therapeutics
  • Bill & Melinda Gates Foundation funding for MIP Discovery

Recent Comments

No comments to show.
  • RSS

Designed by Elegant Themes | Powered by WordPress